Cough Management Guidelines

Introduction to Cough Management

The American Thoracic Society recommends against using dexamethasone as a cough suppressant in most cases, as it provides no significant benefit for symptomatic relief of cough in pertussis and non-specific cough in children, and may cause harm in certain populations 1, 2, 3

Dexamethasone provides no significant benefit for symptomatic relief of cough in pertussis, based on randomized controlled trials 1, 2, 3
No randomized controlled trials support the use of oral steroids, including dexamethasone, for non-specific cough in children 1, 2, 3

Oral dexamethasone is effective for croup, a specific laryngotracheal inflammatory condition, but not for general cough suppression 4
Inhaled corticosteroids, not oral dexamethasone, may help cough when asthma is the underlying cause, using 400 mcg/day beclomethasone or budesonide equivalent for 2-4 weeks 1, 2, 3

The European Respiratory Society recommends identifying the underlying etiology of cough, and using a step-wise approach to management, including trial of inhaled corticosteroids for asthma, topical nasal corticosteroids for upper airway disease, and proton pump inhibitors for GERD 1, 2, 8, 9
The American College of Chest Physicians recommends reassessing patients in 2-4 weeks, and avoiding increasing inhaled corticosteroid doses for unresponsive cough 1, 2, 3

The American Academy of Pediatrics recommends against using dexamethasone as an empiric cough suppressant without identifying a specific steroid-responsive condition, and against prescribing oral corticosteroids for children with non-specific cough or wheeze without confirmed asthma 1, 2, 3
The American Thoracic Society recommends against confusing croup management, where dexamethasone is effective, with general cough suppression, where it is not 4, 11